Given its role as a SDH interaction partner and mitochondrial booster, CART may be suitable for treatment of some debilitating diseases, including mood disorders (MDD), obesity/diabetes, and neurodegenerative diseases. This evidence concerns the gene CARTPT and obesity due to melanocortin 4 receptor deficiency.